Disease of MRNA Regulation: Relevance for Ischemic Brain Injury
Overview
Authors
Affiliations
In this mini-review we give an overview of the role of mRNA-binding proteins and their associated messenger ribonucleoprotein complexes (mRNPs) in several disease states, and bring this information to bear on the pathophysiology of brain ischemia. One conclusion reached is that mRNPs may play a causal role in proteotoxicity instead of being merely passive targets. Ischemia therapies targeting mRNPs have advantages over targeting single pathways, but the behavior of mRNPs needs to be considered in the design of therapies.
Shi X, Liu S, Zou Y, Wu H, Ma J, Lin J Biomedicines. 2024; 12(11).
PMID: 39595085 PMC: 11592331. DOI: 10.3390/biomedicines12112520.
Dhawka L, Palfini V, Hambright E, Blanco I, Poon C, Kahl A Commun Biol. 2024; 7(1):321.
PMID: 38480905 PMC: 10937959. DOI: 10.1038/s42003-024-06009-8.
Maes M, Nikiforov N, Plaimas K, Suratanee A, Alfieri D, Reiche E Int J Mol Sci. 2021; 22(22).
PMID: 34829993 PMC: 8619767. DOI: 10.3390/ijms222212108.
N-methyladenosine (mA) methylation in ischemia-reperfusion injury.
Yao W, Han X, Ge M, Chen C, Xiao X, Li H Cell Death Dis. 2020; 11(6):478.
PMID: 32581252 PMC: 7314846. DOI: 10.1038/s41419-020-2686-7.
McBride D, Gren E, Kelln W, Hayes W, Zhang J J Neurosci Res. 2018; 98(1):191-200.
PMID: 30242872 PMC: 6430696. DOI: 10.1002/jnr.24334.